Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Rhapsody Platform Assay

Becton Dickinson announced the launch of BD Rhapsody, a platform for single cell RNA analysis. According to BD, the system consists of reagents, instruments, and software for targeted gene expression analysis of ten of thousands of individual cells. The platform will also expand beyond RNA expression to include protein detection. BD will offer both application-specific targeted panels and enable customers to design their own custom, targeted panels.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.